On the basis of various epidemiological studies [1] [2] [3] , Helicobacter pylori has been implicated in gastric carcinogenesis. A working group of the World Health Organization International Agency for Research on Cancer concluded that H. pylori is a group I carcinogen in humans [4] . CagA protein, which is encoded by the cagA gene, is one of the most studied virulence factors of H. pylori. H. pylori strains possessing cagA are associated with significantly increased risk for the development of atrophic gastritis and gastric cancer [5] [6] [7] .
On the basis of various epidemiological studies [1] [2] [3] , Helicobacter pylori has been implicated in gastric carcinogenesis. A working group of the World Health Organization International Agency for Research on Cancer concluded that H. pylori is a group I carcinogen in humans [4] . CagA protein, which is encoded by the cagA gene, is one of the most studied virulence factors of H. pylori. H. pylori strains possessing cagA are associated with significantly increased risk for the development of atrophic gastritis and gastric cancer [5] [6] [7] .
The cagA gene is one of several genes of a pathogenicity island (PAI) called the cag PAI. The cag PAI contains 31 genes, 6 of which are thought to encode a putative type IV secretion system, which specializes in the transfer of a variety of multimolecular complexes across the bacterial membrane to the extracellular space or into other cells [8] . Recent studies have provided a molecular basis for the pathological actions of CagA on gastric epithelial cells. After attachment of cagA-positive H. pylori to gastric epithelial cells, CagA is injected directly from the bacteria into the cells via the bacterial type IV secretion system and undergoes tyrosine phosphorylation in the host cells [9] [10] [11] [12] . Furthermore, we recently discovered that translocated CagA forms a physical complex with Src homology 2 domain-containing tyrosine phosphatase (SHP-2) in a phosphorylationdependent manner and stimulates phosphatase activity [13] . SHP-2 is known to play an important positive role in mitogenic signal transduction [14] . In addition, SHP-2 is actively involved in the regulation of spread-ing, migration, and adhesion of cells [15, 16] . Deregulation of SHP-2 by CagA may induce abnormal proliferation and movement of gastric epithelial cells.
H. pylori is genetically more diverse than most bacterial species. Strain-specific genetic diversity has been proposed to be involved in the organism's ability to cause different diseases. There are also indications of significant geographic differences among strains. Only one-half to two-thirds of Western isolates carry cagA. In contrast, nearly all East Asian strains carry cagA [17, 18] . CagA is highly immunogenic and has a molecular weight of 128-140 kDa. Diversity in the size of the protein has been correlated with the presence of a variable number of repeat sequences located in the 3 region of the gene [19, 20] . The phosphorylation sites are located in the repeat region of CagA [21] . Recently, we also discovered that predominant CagA proteins isolated in East Asia, where gastric cancer is prevalent, have a distinct sequence at the region that corresponds to the repeat sequence of Western CagA. After tyrosine phosphorylation, this East Asian-specific sequence confers stronger SHP-2 binding and transforming activities than does the Western CagA-specific sequence [22] . The potential of CagA to disturb host cell functions as a virulence factor could be determined by the degree of SHP-2-binding activity. The diversity of the CagA phosphorylation site, which collectively determines binding affinity of CagA to SHP-2, may be an important variable in determining the clinical outcome of infection by different H. pylori strains.
The incidence of and death rate for gastric cancer in Japan is high, compared with those in other developed countries. However, large intracountry differences in the death rates for gastric cancer have been reported [23] . Fukui is a typical rural prefecture located on the central Japanese mainland (Honshu), whereas Okinawa consists of islands in the southwestern part of Japan and has a history and food culture different from those of other parts of Japan. The 2 areas are separated by 11300 km. The prevalence of atrophic gastritis, a precursor lesion of gastric cancer, is more frequent in Fukui, and the death rate for gastric cancer is 12.4 times higher in Fukui (43.7 deaths/100,000 population in 1999) than in Okinawa (18.2 deaths/100,000 population in 1999). Therefore, we investigated the diversity of CagA phosphorylation sites in isolates from 2 different areas in Japan (Fukui and Okinawa) where gastric cancer risk is different, to examine the association between that diversity and gastric cancer. We also examined the distribution of CagA diversity throughout the world using the data deposited in GenBank.
SUBJECTS, MATERIALS, AND METHODS

Subjects.
One hundred fifteen H. pylori clinical isolates (65 Fukui and 50 Okinawa isolates) were obtained during upper gastroduodenal endoscopy at the Second Department of Internal Medicine of Fukui Medical University and at Okinawa Chubu Hospital, Okinawa, respectively. This work was performed according to the principles of the Declaration of Helsinki, and consent was obtained from each subject after a full description of the nature and protocol of the study was given. The 65 patients in Fukui included 36 with chronic gastritis (17 men and 19 women; mean age, 57.9 years) and 29 with gastric cancer (18 men and 11 women; mean age, 60.0 years). The 50 patients in Okinawa included 42 with chronic gastritis (18 men and 24 women; mean age, 58.6 years) and 8 with gastric cancer (5 men and 3 women; mean age, 61.0 years). All patients were Japanese in origin. Patients who had received nonsteroidal anti-inflammatory drugs were excluded from this study, and none of the patients had recently been prescribed antibiotics. A total of 4 biopsy specimens were obtained from each patient: 2 from the greater curvature of the gastric antral mucosa and 2 from the greater curvature of the gastric corpus mucosa. Each specimen from the antral and corpus mucosa was fixed in 10% buffered formalin (pH 7.2) and subjected to histological analysis. Each specimen from the antral and corpus mucosa was subjected to culture for H. pylori.
Histological analysis. Biopsy specimens were embedded in paraffin and stained with hematoxylin-eosin. Specimens were examined without knowledge of the experimental results. The histological features of chronic gastritis in inflammation (lymphocyte infiltration), activity of gastritis (neutrophil infiltration), and mucosal atrophy were graded on a scale of 0-3, according to the updated Sydney System [24] .
H. pylori culture. Gastric biopsy specimens from each patient were inoculated onto a trypticase soy agar (TSA)-II/ 5% sheep blood plate and cultured under microaerobic conditions (5% O 2 , 15% CO 2 , and 80% N 2 ) for 5 days at 37ЊC. A single colony was picked from each primary culture plate, inoculated onto a fresh TSA-II plate, and cultured under the conditions described above. A few colonies were picked from each plate, transferred into 20 mL of Brucella broth liquid culture medium containing 10% fetal calf serum (FCS), and cultured for 3 days under the same conditions as described above. A part of the liquid culture sample was stored at Ϫ80ЊC in 0.01 mol/L PBS containing 20% glycerol. DNA from each H. pylori isolate was extracted from the pellet of the liquid culture sample by use of the protease/phenol-chloroform method, suspended in 300 mL of a TE buffer (10 mmol/L Tris HCl and 1 mmol/ L EDTA), and stored at 4ЊC until amplification was performed.
Nucleotide sequences of the 3 region of the cagA gene. The 3 region of cagA was amplified by polymerase chain reaction (PCR) by use of the following primers [25] : 5 -GAATTG-TCTGATAAACTTGAAA (forward) and 5 -GCGTATGTGGC-TGTTAGTAGCG (reverse). PCR conditions were as follows: heating for 5 min at 94ЊC, followed by 25 cycles of 30 s at 94ЊC, 30 s at 55ЊC, and 30 s at 72ЊC. The tubes were kept for 7 min at 72ЊC before storage at 4ЊC. PCR products were examined by 2% agarose gel electrophoresis. The gels were stained with ethidium bromide to detect the size of the 3 fragment of the cagA gene. PCR products were then purified with Centricon-100 Concentrator columns (Amicon). DNA sequencing was performed by use of the dideoxynucleotide chain termination method with a BigDye Terminator Cycle Sequencing Ready Reaction Mix (Applied Biosystems) in an ABI PRISM 310 Genetic Analyzer (Applied Biosystems) by use of the same primers shown above and the following additional primers [25] : 5 -GCCCTACCTTACTGAGATCAT and 5 -AGCTTCTGATAC-CGCTTGACTG. In accordance with the manufacturer's protocol, reagent mixtures containing 5 mL of purified PCR product, 3.2 pmol of primer, 8 mL of Terminator Cycle Sequencing Ready Reaction Mix, and 5 mL of sterilized distilled water were prepared. Reaction tubes were placed in the thermal cycler, and thermal cycling was started under the following conditions: 10 s at 96ЊC, 5 s at 50ЊC, and 4 min at 60ЊC, repeated for 25 cycles. Cycle sequencing reactions were performed for both DNA strands. Nucleotide sequences were aligned and analyzed by use of GENTYX-Mac software (version 10.0; Software Development). The previously published cagA gene sequence of strains NCTC11637 (GenBank accession number AE202973) was also included in the analysis. In addition, the cagA sequences deposited in the GenBank database were also characterized in the present study.
In vitro infection. Human gastric epithelial AGS cells were cultured in RPMI 1640 medium (Gibco BRL) containing 10% FCS (Filtron). According to the diversity of the phosphorylation site for in vitro infection, we selected 3 strains for analysis: F32 (a strain isolated from a patient with gastric cancer in Fukui), F65 (a strain isolated from a patient with chronic gastritis in Fukui), and OK112 (a strain isolated from a patient with chronic gastritis in Okinawa). H. pylori ( organisms) were added 8 2 ϫ 10 to AGS cells ( cells/100-mm dish) and cultured in an 6 2 ϫ 10 antibiotics-free medium at an MOI of 100. After incubation in a 5% CO 2 atmosphere for 5 h, infected cells were washed 3 times with 0.01 mol/L PBS (pH 7.5) containing 2 mmol/L Na 3 VO 4 , were lysed in ice-cold lysis buffer (50 mmol/L Tris/ HCl [pH 7.5], 100 mmol/L NaCL, 5 mmol/L EDTA, 1% Brij35, 2 mmol/L Na 3 VO 4 , 10 mg/mL leupeptin, 10 mg/mL aprotinine, 10 mg/mL trypsin inhibitor, and 2 mmol/L phenylmethylsulfonyl fluoride), and were subjected to immunoprecipitation and immunoblotting.
Antibodies. We used anti-CagA polyclonal antibody (Austral Biologicals), anti-phosphotyrosine antibody (4G10; Upstate Biotechnology), and anti-SHP-2 antibody (C-18; Santa Cruz Biotech) as the primary antibodies for immunoprecipitation and immunoblotting.
Immunoprecipitation and immunoblotting. The cell lysates were centrifuged at 10,000 g for 10 min at 4ЊC, and the supernatant was subsequently immunoprecipitated with the antiCagA polyclonal antibody or control normal IgG, for 30 min at 4ЊC, after which protein G-Sepharose beads (Amersham Pharmacia Biotech) were added for 90 min at 4ЊC. The immunoprecipitates were washed 4 times with the lysis buffer and boiled with an electrophoresis SDS sample buffer (2% SDS, 10% glycerol, 6% 2-mercaptoethanol, 0.003% bromophenol blue, and 50 mmol/L Tris/HCl [pH 6.8]) for 5 min. Equal amounts of samples from homogenates or immunoprecipitates were separated by SDS-PAGE (7.5% polyacrylamide) and blotted onto Immobilon P (Millipore). The membranes were blocked with 1% bovine serum albumin or 5% skim milk in T-TBS (10 mmol/L TrisHCl [pH 7.5], 100 mmol/L NaCl, and 0.5% Tween 20) and incubated with a primary antibody in T-TBS overnight at 4ЊC. After washing with T-TBS, the membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG or antimouse IgG polyclonal antibodies in T-TBS for 1 h and were visualized with an enhanced chemiluminescence detection system (Amersham Pharmacia Biotech), as directed by the manufacturer.
Statistical analysis. Results are expressed as median score, , or percentage. Differences in the distribution of mean ‫ע‬ SD diversity of CagA and the associations between the diversity of CagA and clinical outcome were analyzed by use of the x 2 test and Fisher's exact probability test. The grade of inflammation, activity of gastritis, and atrophy among groups were compared by use of the Mann-Whitney U test. Differences for which were considered to be significant. P ! .05
RESULTS
Diversity of the cagA gene. We obtained 2 strains from each patient (1 from corpus and 1 from antrum). In all patients examined, the cagA positivity and cagA nucleotide sequence of the strain isolated from corpus were concordant with those of the strain isolated from antrum. All isolates from Fukui were cagA positive. In contrast, 6 (12.0%) of 50 isolates from Okinawa were cagA negative. All cagA-negative strains were isolated from patients with chronic gastritis. The prevalence of cagApositive H. pylori was significantly different between Fukui and Okinawa ( ) (table 1) . P p .006 The alignment of the deduced amino acid sequence in the 3 region of the cagA gene among strains NCTC11637, OK112, and F32 is shown in figure 1 . We previously reported that NCTC11637 possesses 5 Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs that are potential targets of tyrosine phosphorylation by Src family kinases [22] . These EPIYA motifs are involved in the interaction of CagA with SHP-2. The first and the second EPIYA motifs (which we designated "EPIYA-A" and "EPIYA-B," respectively) are present in almost all CagA proteins, whereas the remaining 3 EPIYA motifs (which we designated "EPIYA-C") were made by duplication of an EPIYA-containing, 34-aa sequence. Because the 34-aa sequence exists in various numbers, ranging from 1 to 3 in most CagA proteins from H. pylori isolated in Western countries, we designated it the "Western CagA-specific, SHP-2-binding sequence" (WSS) [22] . The WSS contains EPIYA-D1, EPIYA-D2, and EPIYA-D3 motifs, as defined by Covacci et al. [19] , or R1 and WSR regions, as defined by Yamaoka et al. [26] . OK112 had a single WSS and was thus classified as the "A-B-C" type, whereas 11637-CagA was classified as the "A-B-C-C-C" type because it had 3 repeats of WSS. The amino acid sequence of CagA from H. pylori isolated in East Asian countries is quite different from that of Western CagA. Predominant East Asia CagA proteins do not have the WSS but, instead, possess a distinct sequence that we designated "East Asian CagA-specific, SHP-2-binding sequence" (ESS) in the corresponding region [22] . ESS contains a JSR region, which has been previously defined by Yamaoka et al. [26] , and also possesses an EPIYA motif, designated "EPIYA-D". F32 had a single ESS and was thus classified as the "A-B-D" type ( figure 1) .
Distribution of CagA diversity and association between the CagA diversity and clinical outcome. The distribution of CagA diversity in Fukui was different from that in Okinawa (table 2) . Although the number of repeats of the EPIYA motif was different among strains, almost all strains isolated from Fukui were East Asian CagA positive and contained the ESS sequence. The F65 strain, which was isolated from a patient with chronic gastritis, did not have either the ESS or WSS ). In both Fukui P p .001 and Okinawa, all strains causing gastric cancer were East Asian CagA positive (table 3) .
Worldwide distribution of CagA diversity. The distribution of CagA diversity throughout the world was examined using the data deposited in GenBank. Nucleotide sequences of the 3 region of cagA were available for 154 strains from GenBank. The distribution of CagA diversity throughout the world is shown in Relationship between histological features and diversity of CagA. We examined the relationship between histological features and the pattern of H. pylori CagA in patients with chronic gastritis. The grade of inflammation and activity of gastritis was significantly higher in patients with chronic gastritis infected with the East Asian CagA-positive strain than in patients with chronic gastritis infected with the cagA-negative strain or Western CagA-positive strain, in both gastric antral and corpus mucosa. The grade of gastric mucosal atrophy was also significantly higher in patients with chronic gastritis infected with the East Asian CagA-positive strain than in patients with chronic gastritis infected with the cagA-negative strain or Western CagA-positive strain, in both gastric antral and corpus mucosa (table 5) . Almost all Fukui strains (except strain F65, which was isolated from a patient with chronic gastritis) carried East Asian CagA. Even in patients infected with East Asian CagA-positive strains, the grade of atrophy in patients with chronic gastritis was significantly higher in Fukui than in Okinawa, in both gastric antral and corpus mucosa (table 5) .
CagA phosphorylation and the binding affinity of CagA to SHP-2. We previously demonstrated that most Japanese H. pylori strains possess a complete cag PAI [25] . In the present study, CagA phosphorylation and the binding affinity of CagA to SHP-2 were examined via in vitro infection by use of 3 strains (F32, F65, and OK112) selected according to the diversity of the phosphorylation site. F32 was the "A-B-D" type, which was the predominant East Asian type, and OK112 was the "A-B-C" type, which was the predominant Western type. We previously reported that the tyrosine residue in EPIYA-C or -D motifs is the major phosphorylation site by in vitro transfection experiments. Strain F65 was the A-B-B type, which did not have a major phosphorylation site. CagA phosphorylation and CagA-SHP-2 binding were detected in the infection with strain OK112 or F32, but they were not detected in the infection with strain F65. The binding affinity of CagA to SHP- 
DISCUSSION
Strain-specific diversity has been proposed to be involved in the ability of H. pylori to cause different diseases. The severity of H. pylori-related disease is correlated with the presence of cag PAI, which is associated with production of the CagA antigen. Infection with cag PAI-positive H. pylori is statistically associated with gastric mucosal atrophy and gastric cancer [5] [6] [7] . Recently, the cagA gene product CagA was shown to be injected into the host cytoplasm through a type IV secretion system and phosphorylated by the host cellular kinases [8] [9] [10] [11] [12] . In addition, CagA forms a physical complex with SHP-2, which is known to play an important positive role in mitogenic signal transduction, and stimulates phosphatase activity [13] . In Japan, nearly 100% of the strains possess a functional cag PAI [18, 25] , and the incidence of atrophic gastritis and gastric cancer is quite high, compared with that in Western countries [27] . We recently discovered, by use of in vitro transfection experiments using a human gastric cancer cell line (AGS), that East Asian CagA has a distinct sequence at the SHP-2 binding site and that the East Asian-specific sequence confers stronger SHP-2 binding and transforming activities than does the Western CagA-specific sequence [22] . We confirmed the results of this in vitro infection study in the present study. East Asian type CagA containing ESS (A-B-D type) conferred stronger SHP-2 binding, compared with Western type CagA (A-B-C type). SHP-2, like its Drosophila homologue, Corkscrew, is known to play an important positive role in mitogenic signal transduction that connects receptor tyrosine kinases and ras [15] . In addition, SHP-2 is actively involved in the regulation of spreading, migration, and adhesion of cells [15, 16] . Deregulation of SHP-2 by CagA may induce abnormal proliferation and movement of gastric epithelial cells. We have also demonstrated a distinct distribution of CagA diversity in East Asia, compared with that in Western countries. The observed distribution may help to explain some of the differences in cagA-positive H. pylori-associated diseases throughout the world. Endemic circulation of H. pylori organisms with more-virulent CagA proteins may affect the prevalence of gastric cancer in East Asian countries. In the present study, to examine the association between the diversity of H. pylori CagA and gastric cancer, we investigated the diversity of CagA phosphorylation sites in isolates from 2 different areas in Japan (Fukui and Okinawa) where the gastric cancer risk is different (the death rate for gastric cancer is 12.4 times higher in Fukui than in Okinawa). In both Fukui and Okinawa, all strains isolated from patients with gastric cancer were East Asian CagA positive. In addition, in Okinawa, the grade of gastric mucosal atrophy was significantly higher in patients with chronic gastritis infected with the East Asian CagA-positive strain than in patients with chronic gastritis infected with the cagA-negative strain or Western CagA-positive strain. These findings suggest that East Asian CagA-positive H. pylori infection correlates with the pathogenesis of atrophic gastritis and gastric cancer. We have previously reported that CagA is actively translocated from the bacteria to gastric epithelial cells, receives tyrosine phosphorylation, and binds SHP-2 in human gastric mucosa in vivo [28] . Of interest, CagA, tyrosine-phosphorylated CagA, and CagA-coimmunoprecipitated endogenous SHP-2 were not detected in the gastric mucosa of patients with intestinal metaplasia or cancer, although they were detected in noncancer mucosal tissue samples obtained from patients with H. pylori-positive early gastric cancer. Chronic gastritis induced by H. pylori infection usually progresses to atrophic gastritis. The risk for gastric cancer increases with the degree and extent of atrophic gastritis. Severe glandular atrophy develops, and intestinal metaplasia occurs, accompanied by the disappearance of H. pylori colonization. This is why CagA, tyrosine-phosphorylated CagA, and CagA-coimmunoprecipitated endogenous SHP-2 were not detected in the gastric mucosa of patients with intestinal metaplasia or cancer; therefore, we suspect that H. pylori infection plays a causative role at a relatively early phase of gastric carcinogenesis. It is possible that deregulation of SHP-2 by translocated CagA may play a role in the acquisition of a cellular-transformed phenotype at a relatively early stage of multistep carcinogenesis in gastric cancer. In the present study, we have shown that the grade of inflammation and activity of gastritis was significantly higher in patients with chronic gastritis infected with the East Asian CagA-positive strain than in patients with chronic gastritis infected with the cagA-negative strain or Western CagA-positive strain. Persistent active inflammation induced by the East Asian CagA-positive strain, which possesses stronger SHP-2 binding than the Western CagA-positive strain, may play a role in the development of atrophic gastritis and gastric cancer.
The results of the present study have indicated that East Asian CagA has strong SHP-2 binding and that infection with East Asian CagA-positive H. pylori induces atrophic gastritis and may play a role in the development of gastric cancer. In addition, even in patients infected with East Asian CagA-positive strains, the grade of atrophy in patients with chronic gastritis was significantly higher in Fukui than in Okinawa. Therefore, other factors, such as environmental and/or host factors, may also affect the grade of atrophy. Recently, polymorphisms in the interleukin-1 gene cluster and HLA genes have been proposed to modulate the risk of gastric cancer [29] [30] [31] . Further analysis of the interaction among H. pylori, the host, and the environment is needed to precisely clarify the pathogenicity of gastric cancer caused by H. pylori infection.
